United States
# |
Name |
Market Capitalization |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 310.22 B |
Jan. 14, 2025 | USD 175.55 | -0.67% |
|
United States |
|
2 |
USD 213.05 B |
Jan. 14, 2025 | USD 556.99 | 0.27% |
|
United States |
|
3 |
USD 171.63 B |
Jan. 14, 2025 | USD 237.62 | -0.94% |
|
United States |
|
4 |
USD 149.67 B |
Jan. 14, 2025 | USD 26.41 | -1.46% |
|
United States |
|
5 |
USD 143.58 B |
Jan. 14, 2025 | USD 267.10 | -1.14% |
|
United States |
|
6 |
USD 138.31 B |
Jan. 14, 2025 | USD 362.80 | 0.50% |
|
United States |
|
7 |
USD 113.41 B |
Jan. 14, 2025 | USD 91.00 | 1.18% |
|
United States |
|
8 |
USD 113.05 B |
Jan. 14, 2025 | USD 55.74 | 0.69% |
|
United States |
|
9 |
USD 106.01 B |
Jan. 14, 2025 | USD 411.66 | -0.41% |
|
United States |
|
10 |
USD 75.92 B |
Jan. 14, 2025 | USD 690.87 | -3.63% |
|
United States |
|
11 |
USD 74.18 B |
Jan. 14, 2025 | USD 164.41 | -1.15% |
|
United States |
|
12 |
USD 41.85 B |
Jan. 14, 2025 | USD 60.89 | 1.60% |
|
United States |
|
13 |
USD 40.96 B |
Jan. 14, 2025 | USD 143.43 | 1.04% |
|
United States |
|
14 |
USD 35.93 B |
Jan. 14, 2025 | USD 197.96 | -3.26% |
|
United States |
|
15 |
USD 31.02 B |
Jan. 14, 2025 | USD 240.51 | -6.88% |
|
United States |
|
16 |
USD 30.92 B |
Jan. 14, 2025 | USD 79.17 | -0.84% |
|
United States |
|
17 |
USD 21.88 B |
Jan. 14, 2025 | USD 165.76 | -2.09% |
|
United States |
|
18 |
USD 21.65 B |
Jan. 14, 2025 | USD 136.48 | -5.37% |
|
United States |
|
19 |
USD 20.85 B |
Jan. 14, 2025 | USD 143.06 | -4.74% |
|
United States |
|
20 |
USD 19.61 B |
Jan. 14, 2025 | USD 234.50 | 0.17% |
|
United States |
|
21 |
USD 17.69 B |
Jan. 14, 2025 | USD 30.03 | 0.13% |
|
United States |
|
22 |
USD 16.28 B |
Jan. 14, 2025 | USD 364.70 | 0.50% |
|
United States |
|
23 |
USD 14.78 B |
Jan. 14, 2025 | USD 21.72 | -1.36% |
|
United States |
|
24 |
USD 14.69 B |
Jan. 14, 2025 | USD 120.73 | -1.61% |
|
United States |
|
25 |
USD 13.86 B |
Jan. 14, 2025 | USD 71.93 | -0.61% |
|
United States |
|
26 |
USD 13.48 B |
Jan. 14, 2025 | USD 126.89 | -0.24% |
|
United States |
|
27 |
USD 13.26 B |
Jan. 14, 2025 | USD 34.46 | -1.96% |
|
United States |
|
28 |
USD 12.28 B |
Jan. 14, 2025 | USD 16.65 | -8.42% |
|
United States |
|
29 |
USD 12.22 B |
Jan. 14, 2025 | USD 68.29 | -0.93% |
|
United States |
|
30 |
USD 12.16 B |
Jan. 14, 2025 | USD 63.81 | -4.75% |
|
United States |
|
31 |
USD 12.01 B |
Jan. 14, 2025 | USD 88.18 | 1.15% |
|
United States |
|
32 |
USD 11.87 B |
Jan. 14, 2025 | USD 74.73 | -2.21% |
|
United States |
|
33 |
USD 11.35 B |
Jan. 14, 2025 | USD 118.83 | 0.34% |
|
United States |
|
34 |
USD 10.18 B |
Jan. 14, 2025 | USD 35.65 | 0.99% |
|
United States |
|
35 |
USD 10.03 B |
Jan. 14, 2025 | USD 54.20 | -7.37% |
|
United States |
|
36 |
USD 9.74 B |
Jan. 14, 2025 | USD 78.14 | -3.73% |
|
United States |
|
37 |
USD 9.58 B |
Jan. 14, 2025 | USD 342.23 | -2.69% |
|
United States |
|
38 |
USD 9.29 B |
Jan. 14, 2025 | USD 61.26 | -2.69% |
|
United States |
|
39 |
USD 9.11 B |
Jan. 14, 2025 | USD 178.08 | -6.34% |
|
United States |
|
40 |
USD 8.77 B |
Jan. 14, 2025 | USD 156.55 | -1.19% |
|
United States |
|
41 |
USD 8.16 B |
Jan. 14, 2025 | USD 147.95 | -2.58% |
|
United States |
|
42 |
USD 7.36 B |
Jan. 14, 2025 | USD 39.83 | -6.44% |
|
United States |
|
43 |
USD 6.85 B |
Jan. 14, 2025 | USD 53.83 | -0.57% |
|
United States |
|
44 |
USD 6.73 B |
Jan. 14, 2025 | USD 35.60 | 5.54% |
|
United States |
|
45 |
USD 6.52 B |
Jan. 14, 2025 | USD 102.56 | -0.77% |
|
United States |
|
46 |
USD 6.44 B |
Jan. 14, 2025 | USD 92.62 | -2.15% |
|
United States |
|
47 |
USD 5.98 B |
Jan. 14, 2025 | USD 274.12 | -9.74% |
|
United States |
|
48 |
USD 5.80 B |
Jan. 14, 2025 | USD 31.64 | -2.65% |
|
United States |
|
49 |
USD 5.41 B |
Jan. 14, 2025 | USD 51.66 | 1.18% |
|
United States |
|
50 |
USD 5.34 B |
Jan. 14, 2025 | USD 45.23 | -3.17% |
|
United States |
The Biotechnology company in United States with the highest Market Capitalization is AbbVie Inc. (NYSE: ABBV) at USD 310.22 B.
The Biotechnology company in United States with the lowest Market Capitalization is Bluejay Diagnostics, Inc. (NasdaqCM: BJDX) at USD 1.86 M.
The top 10 Biotechnology companies in United States by Market Capitalization are AbbVie Inc., Thermo Fisher Scientific Inc., Danaher Corporation, Pfizer Inc., Amgen Inc., Stryker Corporation, Gilead Sciences, Inc., Bristol-Myers Squibb Company, Vertex Pharmaceuticals Incorporated and Regeneron Pharmaceuticals, Inc..
The bottom 10 Biotechnology companies in United States by Market Capitalization are Bluejay Diagnostics, Inc., 60 Degrees Pharmaceuticals, Inc., TransCode Therapeutics, Inc., iSpecimen Inc., Vaccinex, Inc., Alaunos Therapeutics, Inc., LungLife AI, Inc., Dermata Therapeutics, Inc., Qualigen Therapeutics, Inc. and ENDRA Life Sciences Inc..